Women's Health Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Bacterial Vaginosis
New findings from University of Texas in the area of bacterial vaginosis published
June 5th, 2008
According to recent research published in the American Journal of Perinatology, "Our objective was to determine the effect of body mass index (BMI) on response to bacterial vaginosis (BV) treatment. A secondary analysis was conducted of two multi-center trials of therapy for BV and Tricbomonas vaginalis." "Gravida were screened for BV between 8 and 22 weeks and randomized between 16 and 23 weeks to metronidazole or placebo. Of 1497 gravida with asymptomatic BV and preconceptional BMI, 738 were randomized to metronidazole; BMI was divided into categories: < 25, 25 to 29.9, and >= 30. Rates of BV persistence at follow-up were compared using the...
Source: Women's Health Weekly (2008-06-05)
|
